• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用于 LVAD 决策支持工具的成功实施的相关因素的主成分分析。

A principal components analysis of factors associated with successful implementation of an LVAD decision support tool.

机构信息

Center for Medical Ethics and Health Policy, Baylor College of Medicine, One Baylor Plaza MC: 420, Houston, TX, 77030, USA.

Division of Heart Failure, Houston Methodist Hospital, Smith Tower, 6550 Fannin St., Ste 1901, Houston, TX, 77030, USA.

出版信息

BMC Med Inform Decis Mak. 2021 Mar 20;21(1):106. doi: 10.1186/s12911-021-01468-z.

DOI:10.1186/s12911-021-01468-z
PMID:33743685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7980808/
Abstract

BACKGROUND

A central goal among researchers and policy makers seeking to implement clinical interventions is to identify key facilitators and barriers that contribute to implementation success. Despite calls from a number of scholars, empirical insights into the complex structural and cultural predictors of why decision aids (DAs) become routinely embedded in health care settings remains limited and highly variable across implementation contexts.

METHODS

We examined associations between "reach", a widely used indicator (from the RE-AIM model) of implementation success, and multi-level site characteristics of nine LVAD clinics engaged over 18 months in implementation and dissemination of a decision aid for left ventricular assist device (LVAD) treatment. Based on data collected from nurse coordinators, we explored factors at the level of the organization (e.g. patient volume), patient population (e.g. health literacy; average sickness level), clinician characteristics (e.g. attitudes towards decision aid; readiness for change) and process (how the aid was administered). We generated descriptive statistics for each site and calculated zero-order correlations (Pearson's r) between all multi-level site variables including cumulative reach at 12 months and 18 months for all sites. We used principal components analysis (PCA) to examine any latent factors governing relationships between and among all site characteristics, including reach.

RESULTS

We observed strongest inclines in reach of our decision aid across the first year, with uptake fluctuating over the second year. Average reach across sites was 63% (s.d. = 19.56) at 12 months and 66% (s.d. = 19.39) at 18 months. Our PCA revealed that site characteristics positively associated with reach on two distinct dimensions, including a first dimension reflecting greater organizational infrastructure and standardization (characteristic of larger, more established clinics) and a second dimension reflecting positive attitudinal orientations, specifically, openness and capacity to give and receive decision support among coordinators and patients.

CONCLUSIONS

Successful implementation plans should incorporate specific efforts to promote supportive and mutually informative interactions between clinical staff members and to institute systematic and standardized protocols to enhance the availability, convenience and salience of intervention tool in routine practice. Further research is needed to understand whether "core predictors" of success vary across different intervention types.

摘要

背景

寻求实施临床干预的研究人员和政策制定者的一个核心目标是确定有助于实施成功的关键促进因素和障碍。尽管有许多学者呼吁,但对于决策辅助工具(DA)为何会成为医疗保健环境中常规工具的复杂结构和文化预测因素的实证见解仍然有限,并且在实施背景下高度可变。

方法

我们研究了“可及性”(RE-AIM 模型中的一个广泛使用的指标)与 9 个 LVAD 诊所的多层次站点特征之间的关联,这些诊所参与了 18 个月的左心室辅助装置(LVAD)治疗决策辅助工具的实施和传播。根据从护士协调员收集的数据,我们探讨了组织层面的因素(例如患者数量)、患者人群(例如健康素养;平均疾病水平)、临床医生特征(例如对决策辅助工具的态度;变革准备)和流程(辅助工具的管理方式)。我们为每个站点生成了描述性统计数据,并计算了所有站点 12 个月和 18 个月的累积可及性与所有多层次站点变量之间的零阶相关性(皮尔逊 r)。我们使用主成分分析(PCA)来检查控制所有站点特征之间关系的任何潜在因素,包括可及性。

结果

我们观察到我们的决策辅助工具的可及性在第一年急剧上升,第二年的使用率波动不定。所有站点的 12 个月和 18 个月的平均可及性分别为 63%(标准差=19.56)和 66%(标准差=19.39)。我们的 PCA 显示,与可及性相关的站点特征在两个不同维度上呈正相关,包括反映更大的组织基础设施和标准化的第一维度(反映更大、更成熟的诊所的特征),以及反映积极的态度取向的第二维度,具体而言,协调员和患者之间的决策支持的开放性和接受能力。

结论

成功的实施计划应包括具体努力,以促进临床工作人员之间的支持性和相互信息交流,并建立系统和标准化的协议,以提高干预工具在常规实践中的可用性、便利性和突出性。需要进一步研究以了解不同干预类型的成功“核心预测因素”是否存在差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e689/7981944/bea52e3f890d/12911_2021_1468_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e689/7981944/7aeedb45c04b/12911_2021_1468_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e689/7981944/bea52e3f890d/12911_2021_1468_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e689/7981944/7aeedb45c04b/12911_2021_1468_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e689/7981944/bea52e3f890d/12911_2021_1468_Fig2_HTML.jpg

相似文献

1
A principal components analysis of factors associated with successful implementation of an LVAD decision support tool.应用于 LVAD 决策支持工具的成功实施的相关因素的主成分分析。
BMC Med Inform Decis Mak. 2021 Mar 20;21(1):106. doi: 10.1186/s12911-021-01468-z.
2
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Decision Aid Implementation among Left Ventricular Assist Device Programs Participating in the DECIDE-LVAD Stepped-Wedge Trial.参与 DECIDE-LVAD 阶梯式试验的左心室辅助装置项目中的决策辅助工具实施。
Med Decis Making. 2020 Apr;40(3):289-301. doi: 10.1177/0272989X20915227.
5
Shared Decision-Making for Left Ventricular Assist Devices: Rationale and Design of a Nationwide Dissemination and Implementation Project.左心室辅助装置的共同决策:一项全国范围推广和实施项目的原理和设计。
Circ Cardiovasc Qual Outcomes. 2021 Feb;14(2):e007256. doi: 10.1161/CIRCOUTCOMES.120.007256. Epub 2021 Feb 3.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Using Nudges to Enhance Clinicians' Implementation of Shared Decision Making With Patient Decision Aids.运用助推手段促进临床医生借助患者决策辅助工具实施共同决策。
MDM Policy Pract. 2020 Apr 26;5(1):2381468320915906. doi: 10.1177/2381468320915906. eCollection 2020 Jan-Jun.
8
9
Health Literacy in Patients Considering a Left Ventricular Assist Device: Findings From the DECIDE-LVAD Trial.患者左心室辅助装置考虑中的健康素养:DECIDE-LVAD 试验的结果。
J Card Fail. 2022 Aug;28(8):1318-1325. doi: 10.1016/j.cardfail.2022.04.009. Epub 2022 May 13.
10
Organizational factors associated with readiness to implement and translate a primary care based telemedicine behavioral program to improve blood pressure control: the HTN-IMPROVE study.与基于初级保健的远程医疗行为项目的实施和转化相关的组织因素,以改善血压控制:HTN-IMPROVE 研究。
Implement Sci. 2013 Sep 8;8:106. doi: 10.1186/1748-5908-8-106.

引用本文的文献

1
Patients' and physicians' beliefs and attitudes towards integrating personalized risk estimates into patient education about left ventricular assist device therapy.患者和医生对将个性化风险评估整合到左心室辅助设备治疗患者教育中的信念和态度。
Patient Educ Couns. 2024 May;122:108157. doi: 10.1016/j.pec.2024.108157. Epub 2024 Jan 24.

本文引用的文献

1
Evaluating Clinical Implementation Approaches for Prostate Cancer Decision Support.评估前列腺癌决策支持的临床实施方法。
Urol Pract. 2019 Mar;6(2):93-99. doi: 10.1016/j.urpr.2018.05.003. Epub 2018 Mar 20.
2
Using Nudges to Enhance Clinicians' Implementation of Shared Decision Making With Patient Decision Aids.运用助推手段促进临床医生借助患者决策辅助工具实施共同决策。
MDM Policy Pract. 2020 Apr 26;5(1):2381468320915906. doi: 10.1177/2381468320915906. eCollection 2020 Jan-Jun.
3
Implementation of a decision aid for localized prostate cancer in routine care: A successful implementation strategy.
在常规护理中实施局部前列腺癌决策辅助工具:一项成功的实施策略。
Health Informatics J. 2020 Jun;26(2):1194-1207. doi: 10.1177/1460458219873528. Epub 2019 Sep 30.
4
Are Patient Decision Aids Used in Clinical Practice after Rigorous Evaluation? A Survey of Trial Authors.患者决策辅助工具在经过严格评估后是否在临床实践中使用?一项对试验作者的调查。
Med Decis Making. 2019 Oct;39(7):805-815. doi: 10.1177/0272989X19868193. Epub 2019 Aug 17.
5
Introducing Decision Aids into Routine Prostate Cancer Care in The Netherlands: Implementation and Patient Evaluations from the Multi-regional JIPPA Initiative.将决策辅助工具引入荷兰前列腺癌常规护理中:多区域 JIPPA 倡议的实施和患者评估。
J Cancer Educ. 2020 Dec;35(6):1141-1148. doi: 10.1007/s13187-019-01572-9.
6
A Multisite Randomized Controlled Trial of a Patient-Centered Ventricular Assist Device Decision Aid (VADDA Trial).一项以患者为中心的心室辅助装置决策辅助工具(VADDA 试验)的多中心随机对照试验。
J Card Fail. 2018 Oct;24(10):661-671. doi: 10.1016/j.cardfail.2018.08.008. Epub 2018 Sep 7.
7
Organizational- and system-level characteristics that influence implementation of shared decision-making and strategies to address them - a scoping review.影响共享决策实施的组织和系统层面的特征及应对策略:范围综述。
Implement Sci. 2018 Mar 9;13(1):40. doi: 10.1186/s13012-018-0731-z.
8
A three-talk model for shared decision making: multistage consultation process.一种用于共同决策的三阶段谈话模型:多阶段咨询过程。
BMJ. 2017 Nov 6;359:j4891. doi: 10.1136/bmj.j4891.
9
"Provoking conversations": case studies of organizations where Option Grid™ decision aids have become 'normalized'.“引发对话”:关于Option Grid™决策辅助工具已实现“常态化”的组织的案例研究
BMC Med Inform Decis Mak. 2017 Aug 18;17(1):124. doi: 10.1186/s12911-017-0517-2.
10
A guide to using the Theoretical Domains Framework of behaviour change to investigate implementation problems.运用行为改变理论领域框架调查实施问题指南。
Implement Sci. 2017 Jun 21;12(1):77. doi: 10.1186/s13012-017-0605-9.